Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations
In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses treatment strategies for fit patients with AML without targetable mutations.
Decera Clinical Education Oncology Podcast · Ashley Leak Bryant PhD RN OCN FAAN
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses therapeutic options for younger, fit patients with AML and no targetable mutations. Topics include:
- Induction chemotherapy and consolidation therapy
- Use of gemtuzumab ozogamicin
- Management of sinusoidal obstruction syndrome
- Nursing considerations for younger, fit patients with AML
Presenter:
Ashley Leak Bryant, PhD, RN, OCN, FAAN
Associate Professor
School of Nursing
UNC Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.